NAPSRx

Gilead Sciences, Inc. is a biopharmaceutical company whose main focus is centered on discovering, developing and commercializing innovative therapeutics in areas of unmet medical need.

Biogen Idec specializes in the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders.

As one of the industry leaders in the healthcare sector, Novartis retains a positive Q2 report.

AstraZeneca is global pioneer in the biopharmaceutical industry specializing in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare.

Anacor is a biopharmaceutical company whose focus is towards the discovery, development and commercialization of small molecule therapeutics derived from its novel boron chemistry platform.

Boehringer Ingelheim Pharmaceuticals is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and a member of the Boehringer Ingelheim group of companies.

Pfizer's acquisition of InnoPharma is an innovative move which is a part of the Global Established Pharma business and includes the manufacturing, production and sale of the products.

Johnson & Johnson a proven industry leader in the healthcare sector is the first big pharma corporation to unveil the second quarter results for 2014. The pharmaceuticals division made an impressive contribution to the strong sales growth.

The investigational medicine cobimetinib being developed by Exelixis in collaboration with Roche/Genentech, combined with Zelboraf (vemurafenib); showed people with advanced melanoma lived significantly longer without their disease worsening.

With the USA accounting for 34% of the world's pharmaceuticals, representatives are needed to promote new products coming down the pipeline. Meet job requirements with the NAPSRx's pharmaceutical sales training.